Systems Biology Approach for Cancer Vaccine Development and Evaluation
Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy....
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/3/3/544 |
id |
doaj-dc0e5516e3e94e6c93f83872e617092c |
---|---|
record_format |
Article |
spelling |
doaj-dc0e5516e3e94e6c93f83872e617092c2020-11-24T22:30:49ZengMDPI AGVaccines2076-393X2015-07-013354455510.3390/vaccines3030544vaccines3030544Systems Biology Approach for Cancer Vaccine Development and EvaluationLuisa Circelli0Annacarmen Petrizzo1Maria Tagliamonte2Maria Lina Tornesello3Franco M. Buonaguro4Luigi Buonaguro5Laboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyLaboratory of Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale" - IRCCS, Naples 80131, ItalyTherapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy. The newly developed high throughput technologies and computational tools are instrumental to this aim allowing the identification of more specific antigens and the comprehensive analysis of the innate and adaptive immunities. Here, we review the potentiality of systems biology in providing novel insights in the mechanisms of the action of vaccines to improve their design and effectiveness.http://www.mdpi.com/2076-393X/3/3/544systems vaccinologycancer vaccinecancer immunotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luisa Circelli Annacarmen Petrizzo Maria Tagliamonte Maria Lina Tornesello Franco M. Buonaguro Luigi Buonaguro |
spellingShingle |
Luisa Circelli Annacarmen Petrizzo Maria Tagliamonte Maria Lina Tornesello Franco M. Buonaguro Luigi Buonaguro Systems Biology Approach for Cancer Vaccine Development and Evaluation Vaccines systems vaccinology cancer vaccine cancer immunotherapy |
author_facet |
Luisa Circelli Annacarmen Petrizzo Maria Tagliamonte Maria Lina Tornesello Franco M. Buonaguro Luigi Buonaguro |
author_sort |
Luisa Circelli |
title |
Systems Biology Approach for Cancer Vaccine Development and Evaluation |
title_short |
Systems Biology Approach for Cancer Vaccine Development and Evaluation |
title_full |
Systems Biology Approach for Cancer Vaccine Development and Evaluation |
title_fullStr |
Systems Biology Approach for Cancer Vaccine Development and Evaluation |
title_full_unstemmed |
Systems Biology Approach for Cancer Vaccine Development and Evaluation |
title_sort |
systems biology approach for cancer vaccine development and evaluation |
publisher |
MDPI AG |
series |
Vaccines |
issn |
2076-393X |
publishDate |
2015-07-01 |
description |
Therapeutic cancer vaccines do not hold promise yet as an effective anti-cancer treatment. Lack of efficacy or poor clinical outcomes are due to several antigenic and immunological aspects that need to be addressed in order to reverse such trends and significantly improve cancer vaccines’ efficacy. The newly developed high throughput technologies and computational tools are instrumental to this aim allowing the identification of more specific antigens and the comprehensive analysis of the innate and adaptive immunities. Here, we review the potentiality of systems biology in providing novel insights in the mechanisms of the action of vaccines to improve their design and effectiveness. |
topic |
systems vaccinology cancer vaccine cancer immunotherapy |
url |
http://www.mdpi.com/2076-393X/3/3/544 |
work_keys_str_mv |
AT luisacircelli systemsbiologyapproachforcancervaccinedevelopmentandevaluation AT annacarmenpetrizzo systemsbiologyapproachforcancervaccinedevelopmentandevaluation AT mariatagliamonte systemsbiologyapproachforcancervaccinedevelopmentandevaluation AT marialinatornesello systemsbiologyapproachforcancervaccinedevelopmentandevaluation AT francombuonaguro systemsbiologyapproachforcancervaccinedevelopmentandevaluation AT luigibuonaguro systemsbiologyapproachforcancervaccinedevelopmentandevaluation |
_version_ |
1725739175382089728 |